BreastMark: an integrated approach to mining publicly available transcriptomic datasets relating to breast cancer outcome - Wikidata - wikimedia - TriplyDB

BreastMark: an integrated approach to mining publicly available transcriptomic datasets relating to breast cancer outcome

BreastMark: an integrated approach to mining publicly available transcriptomic datasets relating to breast cancer outcome

http://www.wikidata.org/entity/Q37689788

about

Insights into Orphan Nuclear Receptors as Prognostic Markers and Novel Therapeutic Targets for Breast Cancer Prognostic role of microRNA-205 in multiple human malignant neoplasms: a meta-analysis of 17 studies WDR5 Expression Is Prognostic of Breast Cancer Outcome.A genome-wide approach to link genotype to clinical outcome by utilizing next generation sequencing and gene chip data of 6,697 breast cancer patients.Mitochondrial calcium uniporter activity is dispensable for MDA-MB-231 breast carcinoma cell survival Expression of anaesthetic and analgesic drug target genes in excised breast tumour tissue: Association with clinical disease recurrence or metastasis Fibroblast growth factor receptor splice variants are stable markers of oncogenic transforming growth factor β1 signaling in metastatic breast cancers.ERRF sensitizes ERBB2-positive breast cancer cells to lapatinib treatment likely by attenuating MCL1 and ERBB2 expression OvMark: a user-friendly system for the identification of prognostic biomarkers in publically available ovarian cancer gene expression datasets.Downregulation of EphA5 by promoter methylation in human prostate cancer.Functional and molecular characterisation of EO771.LMB tumours, a new C57BL/6-mouse-derived model of spontaneously metastatic mammary cancer.The metastasis suppressor NME1 regulates expression of genes linked to metastasis and patient outcome in melanoma and breast carcinoma.Down-Regulation of miR-92 in Breast Epithelial Cells and in Normal but Not Tumour Fibroblasts Contributes to Breast Carcinogenesis Meta-Analyses of Microarray Datasets Identifies ANO1 and FADD as Prognostic Markers of Head and Neck Cancer Prosaposin activates the androgen receptor and potentiates resistance to endocrine treatment in breast cancer.Polymorphism at 19q13.41 Predicts Breast Cancer Survival Specifically after Endocrine Therapy.ADAM10: a new player in breast cancer progression?Prognostic factor analysis for breast cancer using gene expression profiles.Galectin signatures contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets.Clinical and microarray analysis of breast cancers of all subtypes from two prospective preoperative chemotherapy studies.Automated Ki-67 Quantification of Immunohistochemical Staining Image of Human Nasopharyngeal Carcinoma Xenografts.The C/EBPδ protein is stabilized by estrogen receptor α activity, inhibits SNAI2 expression and associates with good prognosis in breast cancer.NUMB negatively regulates the epithelial-mesenchymal transition of triple-negative breast cancer by antagonizing Notch signaling.LY6E: a conductor of malignant tumor growth through modulation of the PTEN/PI3K/Akt/HIF-1 axis.LOXL4 knockdown enhances tumor growth and lung metastasis through collagen-dependent extracellular matrix changes in triple-negative breast cancer microRNAs: a new class of breast cancer biomarkers.Targeting fibroblast growth factor receptor in breast cancer: a promise or a pitfall?Prognostic and functional importance of the engraftment-associated genes in the patient-derived xenograft models of triple-negative breast cancers.The miR-29 transcriptome in endocrine-sensitive and resistant breast cancer cells.Nuclear respiratory factor-1 and bioenergetics in tamoxifen-resistant breast cancer cells.Bone-Seeking Matrix Metalloproteinase-2 Inhibitors Prevent Bone Metastatic Breast Cancer Growth.LRH-1 controls proliferation in breast tumor cells by regulating CDKN1A gene expression.Tumour but not stromal expression of β3 integrin is essential, and is required early, for spontaneous dissemination of bone-metastatic breast cancer.MCM2: An alternative to Ki-67 for measuring breast cancer cell proliferation.miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and -2.A compilation of Web-based research tools for miRNA analysis.GSTZ1 expression and chloride concentrations modulate sensitivity of cancer cells to dichloroacetate.ErbB2 signaling epigenetically suppresses microRNA-205 transcription via Ras/Raf/MEK/ERK pathway in breast cancer.Complex regulation of LCoR signaling in breast cancer cells.Correlating transcriptional networks to breast cancer survival: a large-scale coexpression analysis.

P2860

Q26795488-C10A5294-4E03-499B-96A1-330482C5ECC3 Q28084872-3CF24EAC-9F56-4DEB-9179-A8DDCE7DE6FC Q30402762-E1DCEAC8-79C7-48BC-92E1-28B889660623 Q31006978-28DE37B1-79C2-4CB3-85F1-9AC4431287B6 Q33573447-F54E558B-3661-4306-AA5C-FA6F94A3C342 Q33739171-D3FF244A-0AA7-43E8-918A-F6D384D8710A Q33739802-BC320D1D-622E-439E-97DD-9F29A520E149 Q33829405-D395711A-1C10-4B55-B62B-80A9256DD19D Q34447404-E83956D1-4899-4DA3-9B53-4C249F2BB5F2 Q35017605-4607B5B4-4DCA-4306-9511-98A86AE7B165 Q35144029-5E7DD532-2142-4234-8727-645619292FFE Q35536511-4B2FFC06-A427-4E39-936F-D518A5242FD1 Q35799412-86EC3C98-215E-4BB5-83CA-40C4D349E514 Q35903521-9007D10E-A037-466F-BD48-16FD82163260 Q36030567-6D5501BB-6512-46EF-97CA-7F47000F28B1 Q36071595-82022EF8-7EEF-44A5-A117-03589DD0B49E Q36081396-10FDCB8A-B975-4AD3-9CC4-03F35F8ABB45 Q36084643-5FAC0D7D-46A3-4991-A979-B4AECE33FCDD Q37109711-6C82BF16-CF36-4F79-9366-FEF232785349 Q37176101-25E75700-2844-47A0-9920-E3CCBF67BEB4 Q37208879-4819DC0F-7287-47BE-8713-E126787C47BF Q37418549-D183AB57-0841-4DF4-AA89-5AEC52D93027 Q37641555-7910563E-289E-4E65-B246-44D652274DAF Q37662321-D673BEAC-00E0-4FBD-8A09-25D82DD861A9 Q37707030-A327A7B8-B3DE-4AB4-988A-BFE6AAE98599 Q38197675-13DF5B97-207F-4608-BD32-6EE8DE248E2C Q38212165-FA2246BE-1F91-4BC5-BF36-36E0EB59C993 Q38421751-F8FBCF95-6881-4CE6-98D4-C221DB8E618C Q38431320-DD5A89F6-B6FE-45EA-9B8E-5A91A283F93F Q38443838-1D139E64-DBD8-4C79-B699-34DDF472764D Q38722186-D92BB0A9-EA3E-45CF-AAFA-0FC6040002D1 Q38936732-00C1BCE4-A681-46B6-8C44-C5A125366301 Q38937289-77850610-D0F3-4B7A-9363-B30C548D9FBC Q39022633-FB7025E2-05B0-43CB-B55A-C44FE4F89D81 Q39028436-D66DF80E-C373-4F3E-A4BA-5EB8DAE9B13E Q39196049-84BAE909-ED8D-4BCD-8115-7E444199B77A Q40359726-5021F8D2-A017-47F7-ACFC-50C52BF3A6AA Q41190480-51DC443E-B10B-406E-BC39-E1069A1FDA0C Q41459796-04AEAE6C-5C45-4464-8AC4-FF2AD5C5B632 Q42439587-B1B36468-69F4-4A64-AC61-AFF7462D40C9

P2860

BreastMark: an integrated approach to mining publicly available transcriptomic datasets relating to breast cancer outcome

http://www.wikidata.org/entity/Q37689788

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

BreastMark: an integrated appr ...... ating to breast cancer outcome

@en

BreastMark: an integrated appr ...... ting to breast cancer outcome.

@nl

type

label

BreastMark: an integrated appr ...... ating to breast cancer outcome

@en

BreastMark: an integrated appr ...... ting to breast cancer outcome.

@nl

prefLabel

BreastMark: an integrated appr ...... ating to breast cancer outcome

@en

BreastMark: an integrated appr ...... ting to breast cancer outcome.

@nl

P1433

Q37689788-58B92EFA-D5BF-4955-BC29-F2AC06A51039

P1476

Q37689788-2633F78D-3A64-4043-A325-47090DDF92C9

P2093

Q37689788-4CF9ECA6-2730-4A7B-982F-64DC4545BC51

Q37689788-5505F2F2-9C54-4012-8A9A-AAE1C36A6C30

Q37689788-91C5FF46-8B81-4284-B007-23A7E456B2BB

Q37689788-E44DD42E-B341-4112-8C8D-DB7DC164F3CC

P2860

Q37689788-016DC1B1-716D-45FE-94DB-2EECABFEC9B5

Q37689788-0638A735-7354-4779-9430-B3901673FAA8

Q37689788-0877B05F-8F6C-40AA-BC0C-E46072CE5C22

Q37689788-0AF1C817-22A3-4E9E-81B8-CD105006F038

Q37689788-0E41F621-E7EB-4747-8DDF-97F4F13DEB62

Q37689788-0E5D0C25-DF25-48C0-A51C-6DD6B2DEA78C

Q37689788-1001CA9C-D927-4BB2-9003-0B656D6B4980

Q37689788-1026B2DC-897A-4EE5-8E1B-7D97AD7E9822

Q37689788-12700F44-178E-4686-833C-47D01CD097DC

Q37689788-1717902D-DC89-476D-B8FF-03C7A5E51B22

P2888

Q37689788-3D60070E-0AC4-4409-AD4A-273B32344CE4

P304

Q37689788-C4B92D9D-A83A-4354-87EE-43200A75ED94

P31

Q37689788-7FD4324F-DB86-4FB7-9461-9690826D8832

P356

Q37689788-1A95FA70-7570-448B-A632-C595E4BE6F65

P433

Q37689788-B6E0F6E3-98A7-40B3-8B3F-DE97083BDC9C

P478

Q37689788-A3E8447F-DA46-49B8-AF83-8E4862FAB4E4

P50

Q37689788-46542E3D-1863-479A-93BA-F9E8B4178832

Q37689788-8AAF297E-7D12-4BC6-AC6B-6F72FC6F1C3B

Q37689788-C99DC080-7064-46BB-B178-4CA31F5B2BB3

Q37689788-D11BEE25-DD6B-4217-8401-F96673F55605

P577

Q37689788-B77A0D25-F8B7-4CC3-B1AD-E64A0CB44E89

P5875

Q37689788-4D44F9E0-4B9A-4D20-AD5F-D57B4DA4CF6A

P6179

Q37689788-F8B1A3AA-87EF-4AFD-B92B-AACE4615649B

P698

Q37689788-A494D444-4C57-4290-BC7B-F29C7A0678A1

P921

Q37689788-BBA9F11C-7CAF-4E05-8A2A-0770713CAD8A

P932

Q37689788-9F791CB0-C5F6-455A-A531-BE6A067F5018

P356

P1433

Breast Cancer Research

P1476

BreastMark: an integrated appr ...... ating to breast cancer outcome

@en

P2093

John Crown

http://www.w3.org/2001/XMLSchema#string

Martin Clynes

http://www.w3.org/2001/XMLSchema#string

Patricia Gaule

http://www.w3.org/2001/XMLSchema#string

Sinead T Aherne

http://www.w3.org/2001/XMLSchema#string

P2860

Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation

Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes

Identification of mammalian microRNA host genes and transcription units

MicroRNAs: target recognition and regulatory functions

Genes that mediate breast cancer metastasis to the brain

MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype

Entrez Gene: gene-centered information at NCBI

Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts.

Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies

FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer

P2888

P304

R52

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/BCR3444

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Norma O'Donovan

William M Gallagher

Stephen F Madden

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

244990812

http://www.w3.org/2001/XMLSchema#string

P6179

1034504213

http://www.w3.org/2001/XMLSchema#string

P698

23820017

http://www.w3.org/2001/XMLSchema#string

P921

P932

3978487

http://www.w3.org/2001/XMLSchema#string